THERAVANCE BIOPHARMA INC
TBPHNASDAQ🏆 #2465 by market capEarnings Nov 10US Equity
$17.04—
Last available close · quote unavailableTrack TBPH
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d▲ 0.0%
ytd▼ 8.8%
1y▲ 20.4%
🏦Market Cap
$884M
Small Cap
📈Revenue Growth (YoY)
66.9%
High Growth
📊Gross Margin
89.4%
High
💵FCF Margin
49.7%
Strong
⚖️P/S Ratio
8.5x
Elevated
Otter Score
72
Strong
Earnings
Q2 · 2026Reported 2026-06-30Earnings Per Share
Actual
0.00
Expected
0.05
miss
−92.20%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
0.00
miss
Q1 2026
-0.03
beat
Q4 2025
0.21
miss
Q3 2025
0.07
beat